Sami Labs, a research and manufacturing arm of Sabinsa Corp. located in Bangalore, India, received funding from India's Department of Scientific and Industrial Research (DSIR) to perform pilot trials on two novel research projects.
Sami Labs was awarded US$185,000 under the department's Technology Development and Demonstration Programme, designed to help promote India's research, development and technology advancements. The grant will be used in part to develop and test a plant-derived cosmetic active, with expected market availability in late 2008. In addition, the grant will assist Sami Labs in developing a novel method to manufacture resveratrol utilizing Sami Labs' patented synthetic demethylation strategy.
"Sami Labs considers this sanction by DSIR as a recognition of its sustained efforts to pioneer and explore novel areas of research to improve human health and wellness," said Muhammed Majeed, PhD, founder and CEO of Sabinsa.